Targeting the oligomerization domain of ETO interferes with RUNX1/ETO oncogenic activity in t(8;21)-positive leukemic cells. [electronic resource]
- Cancer research Mar 2007
- 2280-9 p. digital
Publication Type: Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't